ROCEPHIN W Drug Patent Profile
✉ Email this page to a colleague
When do Rocephin W patents expire, and when can generic versions of Rocephin W launch?
Rocephin W is a drug marketed by Hoffmann La Roche and is included in one NDA.
The generic ingredient in ROCEPHIN W is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rocephin W
A generic version of ROCEPHIN W was approved as ceftriaxone sodium by ANDA REPOSITORY on January 20th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROCEPHIN W?
- What are the global sales for ROCEPHIN W?
- What is Average Wholesale Price for ROCEPHIN W?
Summary for ROCEPHIN W
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | ROCEPHIN W at DailyMed |
US Patents and Regulatory Information for ROCEPHIN W
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hoffmann La Roche | ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER | ceftriaxone sodium | INJECTABLE;INJECTION | 050624-001 | Feb 11, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hoffmann La Roche | ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER | ceftriaxone sodium | INJECTABLE;INJECTION | 050624-002 | Feb 11, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hoffmann La Roche | ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER | ceftriaxone sodium | INJECTABLE;INJECTION | 050624-003 | Feb 11, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |